Mylon LeFevre – MORE – MORE (Of Jesus)


 

Mylon LeFevre – MORE – MORE (Of Jesus) – Classic Christian Rock at its best! Subscribe for more great music! Visit Mylon’s website at www.mylon.org Born into the pioneering Southern gospel family, The Singing LeFevres, Mylon was the youngest son of Eva Mae and Urias LeFevre. When he was old enough, he began to sing and play guitar with the group. The LeFevres were performing at a gospel convention in Memphis. Onstage, singing “Without Him,” Mylon did not know that Elvis Presley was there. After the concert, Elvis asked to meet Mylon. Elvis later recorded the song, and within the next year, over a hundred artists would record his song. In 1970, Mylon signed with Atlantic Records, and formed the “Holy Smoke Doo Dah Band” with Auburn Burrell and JP Lauzon on guitar, drummer Marty Simon, Tom Robb on bass and keyboardist Lester Langdale. From 1970 through 1980, he recorded and performed with Eric Clapton, Elton John, Alvin Lee, Billy Joel, Duane Allman, Berry Oakley, Little Richard, the Who, George Harrison, and Mick Fleetwood, among others. In 1974, he appeared as a fill-in vocalist on several tracks for The Atlanta Rhythm Section’s album Third Annual Pipe Dream. Mylon started getting high to deal with the stress and to fit in. His drug use escalated to a near-fatal overdose of heroin in 1973. So Mylon committed himself to a drug treatment program that year. Seven months later, Mylon came out clean. In 1980, LeFevre attended a concert by the CCM group, 2nd Chapter of Acts. Their long hair, and music showed that they

 

Dr. Manoj Jain: Data, coaching important in changing behavior in health care

Filed under: Memphis Drug Treatment

As a doctor, I treat patients, and I also work as a public health educator, encouraging preventive practices among health care workers, such as washing hands, providing vaccinations and avoiding unnecessary urine or blood catheters. I encourage …
Read more on Memphis Commercial Appeal

 

U.S. Patents Awarded to Inventors in Florida (Sept. 8)

Filed under: Memphis Drug Treatment

Altered levels of expression of specific miRNAs may contribute to cancer development in a variety of cancers such as endometrial cancer and may also influence response to cytotoxic chemotherapy or other cancer treatments. Evidence is provided … 8 …
Read more on Targeted News Service (subscription)

 

Researchers Receive Grants from NCCN Oncology Research Program Funded

Filed under: Memphis Drug Treatment

These grants were made possible through a $ 4-million research grant from GlaxoSmithKline to scientifically evaluate the clinical effectiveness of dabrafenib (GSK2118436) and trametinib (GSK1120212) in treatment of advanced melanoma and other cancers …
Read more on MarketWatch (press release)